Kala White
Family · Columbus, MSNPI 1376670570
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,261 of the $1,456 with a category attached, or 86.6%. It is spread thinly across 14 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $398, 2.5 times the $162 reported in 2021.
Across 66 payments — averaging $22.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$262
- AbbVie$254
- E.r. Squibb & Sons, L.L.C.$239
- Incyte Corporation$167
- LEO Pharma Inc.$117
- Novartis$110
- plus $307 from 8 others
What the payments were for
- Food & beverage$1,26187%
- Education$19513%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 5 | $262 |
| AbbVie(2 entities) | 12 | $254 |
| E.r. Squibb & Sons, L.L.C. | 13 | $239 |
| Incyte Corporation | 10 | $167 |
| LEO Pharma Inc. | 5 | $117 |
| Novartis | 3 | $110 |
| Sun Pharmaceutical Industries Inc. | 4 | $66 |
| Pfizer | 4 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Revance Therapeutics, Inc. | 2 | $39 |
| Amgen | 2 | $30 |
| Galderma Laboratories, L.p. | 2 | $27 |
| Medtronic | 1 | $25 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$1,456 in reported general payments places this provider in the 75th percentile of 3,007 family providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 31 | $2,273 |
| Fluorouracil | 26 | $2,152 |
| Betamethasone Dipropionate | 79 | $2,051 |
| Clindamycin Phosphate | 30 | $976 |
| Triamcinolone Acetonide | 80 | $945 |
| Clobetasol Propionate | 21 | $919 |
| Ketoconazole | 78 | $846 |
| Hydrocortisone | 140 | $829 |
| Mometasone Furoate | 30 | $740 |
| Mupirocin | 91 | $615 |
| Doxycycline Hyclate | 55 | $532 |
| Nystatin | 27 | $348 |
| Gabapentin | 11 | $77 |
| Hydroxyzine Hcl | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other family in Columbus
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
- Andrea WallaceOlive Branch$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.